Testing effectiveness (Phase 2)Study completedNCT04634253What this trial is testingLY3462817 in Participants With Rheumatoid ArthritisWho this might be right forRheumatoid Arthritis Eli Lilly and Company 98
Not applicableUnknownNCT03798028What this trial is testingThe Safety and Effects of Mesenchymal Stem Cell (MSCs) in the Treatment of Rheumatoid ArthritisWho this might be right forRheumatoid Arthritis Xijing Hospital 250
Not applicableStudy completedNCT04574492What this trial is testingOral Upadacitinib Tablets to Assess the Change in Disease Symptoms in Adult Canadian Participants With Moderate to Severe Rheumatoid ArthritisWho this might be right forRheumatoid Arthritis (RA) AbbVie 413
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07377773What this trial is testingQLS12010 in Participants With Moderate-to-severe Rheumatoid ArthritisWho this might be right forRheumatoid Arthritis (RA) Qilu Pharmaceutical Co., Ltd. 180
Testing effectiveness (Phase 2)Study completedNCT04204603What this trial is testingA Study Evaluating the Efficacy and Safety of CKD-506 in Adult Subjects With Moderate-to-Severe Rheumatoid Arthritis and Inadequate Response to MethotrexateWho this might be right forRheumatoid Arthritis Chong Kun Dang Pharmaceutical 122
Post-approval studies (Phase 4)Study completedNCT01443364What this trial is testingOpen Label Study to Assess the Predictability of Early Response to Certolizumab Pegol in Patients With Rheumatoid ArthritisWho this might be right forRheumatoid Arthritis UCB Italy s.p.a. 132
Testing effectiveness (Phase 2)Study completedNCT02296775What this trial is testingComparative Pharmacokinetic, Pharmacodynamic, Safety and Efficacy Study of Three Anti-CD20 Monoclonal Antibodies in Patients With Moderate to Severe Rheumatoid ArthritisWho this might be right forRheumatoid Arthritis Dr. Reddy's Laboratories Limited 276
Large-scale testing (Phase 3)Study completedNCT00535782What this trial is testingThe Effect of Tocilizumab on Markers of Atherogenic Risk in Patients With Moderate to Severe Rheumatoid ArthritisWho this might be right forRheumatoid Arthritis Hoffmann-La Roche 132
Testing effectiveness (Phase 2)Study completedNCT03813199What this trial is testingStudy of Two Doses of ABX464 in Participants With Moderate to Severe Rheumatoid ArthritisWho this might be right forRheumatoid Arthritis Abivax S.A. 60
Large-scale testing (Phase 3)Study completedNCT01710358What this trial is testingA Study in Moderate to Severe Rheumatoid ArthritisWho this might be right forRheumatoid Arthritis Eli Lilly and Company 1,307
Not applicableStudy completedNCT01483326What this trial is testingAn Observational Study on Long-Term Efficacy and Safety of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Rheumatoid Arthritis (FAct)Who this might be right forRheumatoid Arthritis Hoffmann-La Roche 215
Not applicableStudy completedNCT01117480What this trial is testingReal Life Evaluation of Rheumatoid Arthritis in Canadians Taking HUMIRAWho this might be right forModerate-to-severe Rheumatoid Arthritis AbbVie (prior sponsor, Abbott) 1,013
Large-scale testing (Phase 3)Study completedNCT03980483What this trial is testingEfficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to MethotrexateWho this might be right forArthritis, Rheumatoid GlaxoSmithKline 1,537
Early research (Phase 1)Looking for participantsNCT07207954What this trial is testingStudy of LFD-200 in Healthy Adults and Adults With Moderate to Severe Rheumatoid ArthritisWho this might be right forRheumatoid Arthritis Lifordi Immunotherapeutics, Inc. 176
Testing effectiveness (Phase 2)Ended earlyNCT05516758What this trial is testingPeresolimab (LY3462817) in Participants With Moderately-to-Severely Active Rheumatoid ArthritisWho this might be right forRheumatoid ArthritisArthritisJoint Diseases+5 more Eli Lilly and Company 491
Testing effectiveness (Phase 2)Study completedNCT01960855What this trial is testingA Study Investigating the Efficacy and Safety of ABT-494 Given With Methotrexate in Subjects With Rheumatoid Arthritis Who Failed Anti-Tumor Necrosis Factor (TNF) Biologic TherapyWho this might be right forRheumatoid Arthritis AbbVie 276
Testing effectiveness (Phase 2)Study completedNCT02638948What this trial is testingEfficacy and Safety Study of BMS-986142 in Patients With Moderate to Severe Rheumatoid ArthritisWho this might be right forRheumatoid Arthritis Bristol-Myers Squibb 508
Large-scale testing (Phase 3)Study completedNCT00996606What this trial is testingTocilizumab in Combination With Disease-Modifying Anti-Rheumatic Drugs (DMARDs) in Participants With Moderate to Severe Active Rheumatoid Arthritis With an Inadequate Response to DMARDsWho this might be right forRheumatoid Arthritis Hoffmann-La Roche 58
Post-approval studies (Phase 4)Study completedNCT01500278What this trial is testingStudy to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to MethotrexateWho this might be right forRheumatoid Arthritis UCB Pharma SA 915
Testing effectiveness (Phase 2)Study completedNCT00595413What this trial is testingAtacicept in Anti-Tumor Necrosis Factor Alpha-naïve Subjects With Rheumatoid Arthritis (AUGUST II)Who this might be right forRheumatoid Arthritis EMD Serono 311